Valion Bio, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $12.6M | $2.0M | $3.4M | $3.5M | $13.0M |
| Accounts Receivable | — | $69.0K | $174.0K | $107.0K | $92.0K |
| Inventory | $0 | $319.0K | $756.0K | $863.0K | $429.0K |
| Total Current Assets | $13.0M | $2.6M | $4.7M | $5.3M | $14.3M |
| Property, Plant & Equipment | $12.6M | $2.0K | $122.0K | $12.0K | $11.0K |
| Goodwill | $3.5M | $0 | — | — | — |
| Intangible Assets (Excl. Goodwill) | $2.2M | $0 | — | — | — |
| Total Assets | $31.6M | $2.8M | $5.2M | $5.9M | $15.0M |
| Liabilities | |||||
| Accounts Payable | $264.0K | $125.0K | $713.0K | $1.3M | $789.0K |
| Total Current Liabilities | $646.0K | $272.0K | $1.4M | $1.9M | $1.2M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $7.4M | $272.0K | $1.6M | $2.2M | $1.8M |
| Stockholders' Equity | |||||
| Retained Earnings | $-52.6M | $-43.5M | $-37.9M | $-29.6M | $-19.5M |
| Total Stockholders' Equity | $16.8M | $2.5M | $3.6M | $3.6M | $13.3M |